Biotech · Private company · Palo Alto, CA, US
Halo Biosciences, Inc.
Track this companyFree. Adds Halo Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH)Fiscal year 2025 · $1MNIH RePORTER 5R44HL169052-02 · fetched Nov 12, 2026
- Development of a Novel Hyaluronan Inhibitor for the Treatment of Group 3 Pulmonary Hypertension (PH)Fiscal year 2024 · $2MNIH RePORTER 1R44HL169052-01A1 · fetched Nov 12, 2026